These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12150328)

  • 1. GAD antigen and its significance in type I diabetes.
    Hawa MI; Leslie RD
    J Endocrinol Invest; 2002; 25(7):576. PubMed ID: 12150328
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD; Atkinson MA; Notkins AL
    Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 5. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
    Atkinson M; Leslie DR
    J Endocrinol Invest; 1994; 17(7):581-4. PubMed ID: 7829833
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
    Lühder F; Woltanski KP; Hamann J; Klöting I; Ziegler B; Ziegler M
    Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.
    Christie MR; Hollands JA; Brown TJ; Michelsen BK; Delovitch TL
    J Clin Invest; 1993 Jul; 92(1):240-8. PubMed ID: 8325989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has GAD a central role in type 1 diabetes?
    Yoon JW; Sherwin RS; Kwon H; Jun HS
    J Autoimmun; 2000 Nov; 15(3):273-8. PubMed ID: 11040067
    [No Abstract]   [Full Text] [Related]  

  • 10. GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.
    Solimena M; Butler MH; De Camilli P
    J Endocrinol Invest; 1994; 17(7):509-20. PubMed ID: 7829825
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Cooke A; Mandel TE
    J Endocrinol Invest; 1994; 17(7):586-93. PubMed ID: 7829835
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies in Type 1 diabetes.
    Schmidt KD; Valeri C; Leslie RD
    Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
    Cooke A; Mandell T
    J Endocrinol Invest; 1994; 17(7):585-93. PubMed ID: 7829834
    [No Abstract]   [Full Text] [Related]  

  • 14. [GAD antibodies, GAD65 antibody].
    Yamanouchi T
    Nihon Rinsho; 1999 Dec; 57 Suppl():372-5. PubMed ID: 10778142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoantibodies against GAD and GAD65].
    Tsujii S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():190-5. PubMed ID: 9513413
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-chemistry of hydroxyl radical modified GAD-65: A possible role in experimental and human diabetes mellitus.
    Moinuddin ; Ansari NA; Shahab U; Habeeb S; Ahmad S
    IUBMB Life; 2015 Oct; 67(10):746-56. PubMed ID: 26362234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-parameter model for prediction of type I diabetes mellitus.
    Eisenbarth GS; Gianani R; Yu L; Pietropaolo M; Verge CF; Chase HP; Redondo MJ; Colman P; Harrison L; Jackson R
    Proc Assoc Am Physicians; 1998; 110(2):126-35. PubMed ID: 9542768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
    Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
    Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.